Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE-Reference-Cited by-同舟云学术

Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE

Published:2023-08 Issue: Volume:189 Page:112917
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hescot Ségolène,Debien Véronique,Hadoux Julien,Drui Delphine,Haissaguerre Magalie,de la Fouchardiere Christelle,Vezzosi Delphine,Do Cao Christine,Libé Rossella,Le Tourneau Christophe,Baudin Eric,Massard Christophe,du Rusquec Pauline

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Adrenocortical carcinoma;Baudin;Endocrinol Metab Clin North Am,2015

2. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection;Beuschlein;J Clin Endocrinol Metab,2015

3. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study;Libé;Ann Oncol,2015

4. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors;Fassnacht;Eur J Endocrinol,2018

5. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up;Fassnacht;Ann Oncol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A computed tomography-based radiomic score to predict survival in patients with adrenocortical carcinoma;2024-02-02